Tanamoto K - Search Results

1

The induction of super-resistance using synthetic lipopolysaccharide receptor agonist rescues fatal endotoxemia in rats without excessive immunosuppression.

Hatao F, Hiki N, Mimura Y, Ogawa T, Kojima J, Mafune K, Hawkins LD, Muroi M, Tanamoto K, Kaminishi M. Hatao F, et al. Among authors: tanamoto k. Shock. 2005 Apr;23(4):365-70. doi: 10.1097/01.shk.0000158961.01456.b9. Shock. 2005. PMID: 15803061

2

The polysaccharide portion plays an indispensable role in Salmonella lipopolysaccharide-induced activation of NF-kappaB through human toll-like receptor 4.

Muroi M, Tanamoto K. Muroi M, et al. Among authors: tanamoto k. Infect Immun. 2002 Nov;70(11):6043-7. doi: 10.1128/IAI.70.11.6043-6047.2002. Infect Immun. 2002. PMID: 12379680 Free PMC article.

3

Effect of endocrine disrupting chemicals on lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production by mouse macrophages.

Hong CC, Shimomura-Shimizu M, Muroi M, Tanamoto K. Hong CC, et al. Among authors: tanamoto k. Biol Pharm Bull. 2004 Jul;27(7):1136-9. doi: 10.1248/bpb.27.1136. Biol Pharm Bull. 2004. PMID: 15256756 Free article.

4

Prolonged Toll-like receptor stimulation leads to down-regulation of IRAK-4 protein.

Hatao F, Muroi M, Hiki N, Ogawa T, Mimura Y, Kaminishi M, Tanamoto K. Hatao F, et al. Among authors: tanamoto k. J Leukoc Biol. 2004 Oct;76(4):904-8. doi: 10.1189/jlb.0504277. Epub 2004 Jul 16. J Leukoc Biol. 2004. PMID: 15258191

5

Structural regions of MD-2 that determine the agonist-antagonist activity of lipid IVa.

Muroi M, Tanamoto K. Muroi M, et al. Among authors: tanamoto k. J Biol Chem. 2006 Mar 3;281(9):5484-91. doi: 10.1074/jbc.M509193200. Epub 2005 Dec 31. J Biol Chem. 2006. PMID: 16407172 Free article.

6

The lipopolysaccharide-recognition mechanism in cells expressing TLR4 and CD14 but lacking MD-2.

Ohnishi T, Muroi M, Tanamoto K. Ohnishi T, et al. Among authors: tanamoto k. FEMS Immunol Med Microbiol. 2007 Oct;51(1):84-91. doi: 10.1111/j.1574-695X.2007.00281.x. Epub 2007 Jul 5. FEMS Immunol Med Microbiol. 2007. PMID: 17614960 Free article.

7

MyD88-induced downregulation of IRAK-4 and its structural requirements.

Hatao F, Yamamoto M, Muroi M, Kaminishi M, Tanamoto K. Hatao F, et al. Among authors: tanamoto k. FEMS Immunol Med Microbiol. 2008 Jul;53(2):260-4. doi: 10.1111/j.1574-695X.2008.00425.x. Epub 2008 May 21. FEMS Immunol Med Microbiol. 2008. PMID: 18503546 Free article.

8

A novel TLR4-binding peptide that inhibits LPS-induced activation of NF-kappaB and in vivo toxicity.

Sugiyama K, Muroi M, Tanamoto K. Sugiyama K, et al. Among authors: tanamoto k. Eur J Pharmacol. 2008 Oct 10;594(1-3):152-6. doi: 10.1016/j.ejphar.2008.07.037. Epub 2008 Jul 30. Eur J Pharmacol. 2008. PMID: 18700140

9

AKT1 distinctively suppresses MyD88-depenedent and TRIF-dependent Toll-like receptor signaling in a kinase activity-independent manner.

Zenke K, Muroi M, Tanamoto KI. Zenke K, et al. Among authors: tanamoto ki. Cell Signal. 2018 Mar;43:32-39. doi: 10.1016/j.cellsig.2017.12.002. Epub 2017 Dec 11. Cell Signal. 2018. PMID: 29242168

10

Regions of the mouse CD14 molecule required for toll-like receptor 2- and 4-mediated activation of NF-kappa B.

Muroi M, Ohnishi T, Tanamoto K. Muroi M, et al. Among authors: tanamoto k. J Biol Chem. 2002 Nov 1;277(44):42372-9. doi: 10.1074/jbc.M205966200. Epub 2002 Aug 23. J Biol Chem. 2002. PMID: 12196527 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters